Protection of healthcare workers from bloodborne pathogens

Current Opinion in Infectious Diseases

Volumn 18, Issue 4, 2005, Pages 331-336

  Beekmann, Susan E ^a,c   Henderson, David K ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Pathology 265 MRC   (United States)

Author keywords

Bloodborne pathogens; Healthcare workers; HIV transmission

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; VACCINE; ZIDOVUDINE;

BLOODBORNE BACTERIUM; CHEMOPROPHYLAXIS; DIARRHEA; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; FATIGUE; HEADACHE; HEALTH CARE PERSONNEL; HEART FAILURE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; LIVER TOXICITY; NAUSEA; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRACTICE GUIDELINE; PREDICTION; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SAFETY; SIDE EFFECT; SKIN TOXICITY; TOXICITY; VACCINATION; VOMITING;

EID: 22544481485     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000171921.52433.50     Document Type: Review

References (50)

1. Garner JS. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:53-80.
2. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mort Wkly Rep 1987; 36 (Suppl 2):1S-18S.
3. Panlilio AL, Orelien JG, Srivastava PU, et al. Estimate of the annual number of percutaneous injuries among hospital-based healthcare workers in the United States, 1997-1998. Infect Control Hosp Epidemiol 2004; 25:556-562. An important paper providing an estimate of the total percutaneous injuries sustained annually by hospital-based healthcare workers in the US.
4. Fisker N, Mygind LH, Krarup HB, et al. Blood borne viral infections among Danish health care workers: frequent blood exposure but low prevalence of infection. Eur J Epidemiol 2004; 19:61-67.
5. Haiduven D, Ferrol S. Sharps injuries in the home health care setting: risks for home health care workers. AAOHN J 2004; 52:102-108.
6. Moens G, Mylle G, Johannik K, et al. Analysing and interpreting routinely collected data on sharps injuries in assessing preventative actions. Occup Med (Lond) 2004; 54:245-249.
7. Kotelchuck D, Murphy D, Younai F. Impact of underreporting on the management of occupational bloodborne exposures in a dental teaching environment. J Dent Educ 2004; 68:614-622.
8. Watterson L. Monitoring sharps injuries: EPINet surveillance results. Nurs Stand 2004; 19:33-38.
9. Dement JM, Epling C, Ostbye T, et al. Blood and body fluid exposure risks among health care workers: results from the Duke health and surveillance system. Am J Ind Med 2004; 46:637-648.
10. Yang Y-H, Wu M-T, Ho C-K, et al. Needlestick/sharps injuries among vocational school nursing students in southern Taiwan. Am J Infect Cont 2004; 32:431-435.
11. Kosgeroglu N, Ayranci U, Vardareli E, Dincer S. Occupational exposure to hepatitis infection among Turkish nurses: frequency of needle exposure, sharps injuries and vaccination. Epidemiol Infect 2004; 132:27-33.
12. Sohn S, Eagan J, Sepkowitz KA, Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol 2004; 25:536-542. Provides details of a whole-hospital program that effectively reduced percutaneous injuries by implementing safety-engineered devices and an education program.
13. Sohn S, Eagan J, Sepkowitz KA. Safety-engineered device implementation: does it introduce bias in percutaneous injury reporting? Infect Control Hosp Epidemiol 2004; 25:543-547. Provides data to alleviate the concern that decreases in injuries from pre to postintervention were related to more underreporting rather than fewer injuries.
14. Vaughn TE, McCoy KD, Beekmann SE, et al. Factors promoting consistent adherence to safe needle precautions among hospital workers. Infect Control Hosp Epidemiol 2004; 25:548-555. This paper reports organizational factors and occupational characteristics associated with adherence to occupational safety guidelines.
15. Ferguson KJ, Waitkin H, Beekmann SE, Doebbeling BN. Critical incidents of nonadherence with standard precautions guidelines among community hospital-based health care workers. J Gen Intern Med 2004; 19:726-731. This paper provides a qualitative analysis of healthcare workers' responses to a survey question asking about critical incidents of nonadherence to standard precautions.
16. Lymer U-B, Rieht B, Isaksson B. Blood exposure: factors promoting health care workers' compliance with guidelines in connection with risk. J Clin Nurs 2004; 13:547-554.
17. Trape-Cardoso M, Schenck P. Reducing percutaneous injuries at an academic health center: a 5-year review. Am J Infect Cont 2004; 32:301-305. A review of injuries at one US hospital that provides guidance for administrative, educational, and engineering control interventions to reduce risk.
18. Rogues AM, Verdun-Esquer C, Buisson-Valles I, et al. Impact of safety devices for preventing percutaneous injuries related to phlebotomy procedures in health care workers. Am J Infect Control 2004; 32:441-444. This paper provides data showing that sharp injury rates dropped in a French hospital after implementation of two phlebotomy safety devices.
19. Stone PW, Clarke SP, Cimiotti J, Correa-de-Araujo R. Nurses' working conditions: implications for infectious diseases. Emerg Infect Dis 2004; 10:1984-1989. An excellent review of how staffing patterns and nurses' working conditions are risk factors for occupational injuries.
20. Dement JM, Pompeii LA, Ostbye T, et al. An integrated comprehensive occupational surveillance system for health care workers. Am J Ind Med 2004; 45:528-538.
21. Bennett G, Mansell I. Universal precautions: a survey of community nurses' experience and practice. J Clin Nurs 2004; 13:413-421.
22. Cutter J, Jordan S. Uptake of guidelines to avoid and report exposure to blood and body fluids. J Adv Nurs 2004; 46:441-452. A British study of the adoption of preventive measures by surgical personnel.
23. Duffy RE, Cleveland JL, Hutin YJ, Cardo D. Evaluating infection control practices among dentists in Valcea, Romania, in 1998. Infect Control Hosp Epidemiol 2004; 25:570-575.
24. Suzuki K, Ohida T, Kaneita Y, et al. Mental health status, shift work, and occupational accidents among hospital nurses in Japan. J Occup Health 2004; 46:448-454. A questionnaire study of nurses in Japan regarding the association between mental health status and four types of medical accidents, including needlestick injuries.
25. Rivers DL, Aday LA, Frankowski RF, et al. Predictors of nurses' acceptance of an intravenous catheter safety device. Nurs Res 2003; 52:249-255.
26. Perry J, Robinson ES, Jagger J. Needle-stick and sharps-safety survey: getting to the point about preventable injuries. Nursing 2004; 34:43-47.
27. Alweis RL, DiRosario K, Conidi G, et al. Serial nosocomial transmission of Plasmodium falciparum malaria from patient to nurse to patient. Infect Control Hosp Epidemiol 2004; 25:55-59.
28. Tarantola AP, Rachline AC, Konto C, et al. Occupational malaria following needlestick injury. Emerg Infect Dis 2004; 10:1878-1879.
29. Nemes Z, Kiss G, Madarassi EP, et al. Nosocomial transmission of dengue. Emerg Infect Dis 2004; 10:1880-1881.
30. Wagner D, de With K, Huzly D, et al. Nosocomial acquisition of dengue. Emerg Infect Dis 2004; 10:1872-1873.
31. Centers for Disease Control and Prevention. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mort Wkly Rep 1996; 45:468-472.
32. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposure to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mort Wkly Rep 2001; 50:1.
33. Rey D, Bendiane M-K, Moatti J-P, et al. Post-exposure prophylaxis after occupational and non-occupational exposures to HIV: an overview of the policies implemented in 27 European countries. AIDS Care 2000; 6:695-701.
34. Puro V, Cicalini S, De Carli G, et al. Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. Eur J Epidemiol 2004; 19:577-584. Rationale and recommendations for antiretroviral postexposure prophylaxis in Europe.
35. Bassett IV, Freedberg KA, Walensky RP. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis 2004; 39:395-401. Decision modeling to assist with the decision to provide two-drug versus three-drug PEP.
36. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR Morb Mort Wkly Rep 2005; 54: 1-20. US Public Health Service recommendations for antiretroviral PEP after nonoccupational exposure to HIV.
37. Feldt T, Cette M, Wenning M, et al. Haemodynamic crisis and reversible multiorgan failure caused by HIV post-exposure prophylaxis after needle-stick injury in a health care worker. HIV Med 2004; 5:125-127.
38. Henderson DK. HIV postexposure prophylaxis in the 21st century. Emerg Infect Dis 2001; 7:254-258.
39. Bangsberg D, Goldschmidt RH. Postexposure prophylaxis for occupational exposure to HIV. JAMA 1999; 282:1623-1624.
40. Patel SM, Johnson S, Belknap SM, et al. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 2004; 35:120-125.
41. Zou S, Notari EP, Stramer SL, et al. Patterns of age- and sex-specific prevalence in major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004; 44:1640-1647. Temporal trends for age and sex-specific prevalence of HIV, hepatitis B and C from 1995 to 2002 based on American Red Cross data.
42. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 2004; 94:1218-1223.
43. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41:88-96.
44. Jarrosson L, Kolopp-Sarda MN, Aguilar P, et al. Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. Vaccine 2004; 22:3789-3796.
45. Henderson DK. Managing occupational risks for hepatitis C transmission in the healthcare setting. Clin Microbiol Rev 2003; 16:546-568.
46. Alvarado-Ramy F, Alter MJ, Bower W, et al. Management of occupational exposures to hepatitis C virus: current practice and controversies. Infect Control Hosp Epidemiol 2001; 22:53-55.
47. Larghi A, Zuin M, Crosignani A, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36:993-1000.
48. Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C. Hepatology 2002; 36:S1-S2.
49. Alberti A, Boccato S, Vario A, Benvegnu L. Therapy of acute hepatitis C. Hepatology 2002; 36:S195-S200.
50. Henderson DK. How're we doin'? Preventing occupational infections with blood-borne pathogens in healthcare. Infect Control Hosp Epidemiol 2004; 25:532-535. An editorial reviewing several papers focused on preventing occupational infections with bloodborne pathogens.